FRI a Method of Reading Cardiotocography (CTG) in Labor
FINIS
Fetal Reserve Index (FRI) as a Tool for Improving Surveillance Cardiotocography in Labor.
1 other identifier
interventional
290
1 country
1
Brief Summary
The objective of the study is to investigate the FRI's ability to identify cases requiring urgent intervention which will present an adverse perinatal outcome (respiratory acidosis, metabolic acidosis, Apgar index, etc.) compared to the classical interpretation of CTG. Patients whose CTG in labor will be considered non-reassuring will be enrolled and randomized into two groups. The "Fetal Reserve Index" algorithm will be applied to the first group of patients. The second group of patients will, however, be managed according to the usual protocols internal management.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 25, 2024
CompletedFirst Posted
Study publicly available on registry
July 1, 2024
CompletedStudy Start
First participant enrolled
July 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedJuly 1, 2024
June 1, 2024
11 months
June 25, 2024
June 25, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
number of cases requiring urgent intervention
number of cases requiring urgent intervention (vaginal operative delivery / urgent cesarean section) identified by the FRI
12 MONTHS
Secondary Outcomes (1)
number of cases that will present a perinatal outcome adverse events
12 MONTHS
Study Arms (2)
group A (FRI)
ACTIVE COMPARATORThe "Fetal Reserve Index" algorithm will be applied to the first group of patients. In in these patients the fetal reserve index will be calculated every 10 minutes.. For patients with abnormal FRI a 40 minute timer will be started within which it will be necessary to exit the "red zone". If such patients will not be able to exit the red zone within 40 minutes, an additional timer will be started of 30 minutes within which the birth will be completed.
group B (No FRI)
ACTIVE COMPARATORThe second group of patients will, however, be managed according to the usual protocols internal management.
Interventions
At each of the components of the score will be assigned a score of 1 if the variable evaluated is considered normal, 0 if classified as abnormal. To encourage a simplified clinical interpretation of the different scores obtained (score from 1 to 8) they will be classified into 3 risk categories: Score 5-8: green zone, Score 3-4: zone yellow, Score 1-2: red zone. An FRI of 1-2 (red zone) is to be considered as anomalous
evaluate the CTG of group B patients according to the usual internal management protocols
Eligibility Criteria
You may qualify if:
- Women in the active phase of labor who presented when they entered the room I delivered a negative admission test (i.e. a normoreactive CTG according to ACOG) and that subsequently present during labor a diagnosis of category II CTG
- Single term pregnancy
- Signature of informed consent
You may not qualify if:
- Failure to sign the informed consent
- Previous caesarean section (TOLAC)
- Twin pregnancy
- Gestational age \<37 weeks
- Known genetic/chromosomal syndromes and/or malformations, excluding heart disease without contraindication to vaginal birth
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fondazione Policlinico Universitario A. Gemelli IRCCS
Roma, 00168, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Angela BOTTA
Fondazione Policlinico Universitario A. Gemelli, IRCCS
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 25, 2024
First Posted
July 1, 2024
Study Start
July 1, 2024
Primary Completion
June 1, 2025
Study Completion
December 1, 2025
Last Updated
July 1, 2024
Record last verified: 2024-06